Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 10, 2010, Pages 4518-4519

  Jones, Ronald N ^a   Biedenbach, Douglas J ^a   Roblin, Patricia M ^b   Kohlhoff, Stephan A ^b   Hammerschlag, Margaret R ^b  

^a JMI LABORATORIES   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CEM 102; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; FUSIDIC ACID; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CHLAMYDIA TRACHOMATIS; FUSIDIC ACID; NEISSERIA GONORRHOEAE;

EID: 77957336949     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00235-10     Document Type: Letter

References (14)

1. Adimora, A. A. 2002. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin. Infect. Dis. 35(Suppl. S2):183-186.
2. Centers for Disease Control and Prevention. 2002. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR Morb. Mortal. Wkly. Rep. 51:1041-1044.
3. Centers for Disease Control and Prevention. 2006. Update to CDC's sexually transmitted diseases treatment guidelines, "Fluoroquinolones no longer recommended for treatment of gonococcal infections." MMWR Morb. Mortal. Wkly. Rep. 56:332-336.
4. Clinical and Laboratory Standards Institute. 2009. M07-A8. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2010. M100-S20. Performance standards for antimicrobial susceptibility testing, 20th informational supplement. CLSI, Wayne, PA.
6. Coonrod, D. V. 2002. Chlamydial infections. Curr. Womens Health Rep. 2:266-275.
7. Creighton, S., M. Tenant-Flowers, C. B. Taylor, R. Miller, and N. Low. 2003. Co-infection with gonorrhoeae and chlamydia: How much is there and what does it mean? Int. J. STD AIDS 14:109-113. (Pubitemid 36183018)
8. Godtfredsen, W., K. Roholt, and L. Tybring. 1962. FUCIDIN. A new orally active antibiotic. Lancet 279:928-931.
9. Merchant, R. C., D. M. Depalo, M. D. Stein, and J. D. Rich. 2009. Adequacy of testing, empiric treatment, and referral for adult male emergency department patients with possible chlamydia and/or gonorrhoea urethritis. Int. J. STD AIDS 20:534-539.
10. Olanrewaju, O. O., J. B. Bulitta, A. Forrest, B. T. Tsuji, S. M. Bhavnani, J. G. Still, P. Fernandes, and P. G. Ambrose. 2009. CEM-102 (sodium fusidate) dosage regimen decision support using population pharmacokinetic (PPK) and mechanism-based pharmacokinetic-pharmacodynamic (PKPD) models, abstr. A-1141. Abstr. 47th Annu. Meet. Infect. Dis. Soc. Am. Infectious Diseases Society of America, Philadelphia, PA.
11. Palmer, H. M., H. Young, A. Winter, and J. Dave. 2008. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J. Antimicrob. Chemother. 62:490-494.
12. Roberts, M. C., W. O. Chung, D. Roe, M. Xia, C. Marquez, G. Borthagaray, W. L. Whittington, and K. K. Holmes. 1999. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob. Agents Chemother. 43:1367-1372.
13. Roblin, P. M., and M. R. Hammerschlag. 1998. Microbiologic efficacy of azithromycin and susceptibility to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community acquired pneumonia. Antimicrob. Agents Chemother. 42:194-196.
14. Still, J. G., K. Clark, T. P. Degenhardt, D. Scott, P. Fernandes, and M. J. Gutierrez. 2009. Pharmacokinetics and safety of single, multiple, and loading doses of CEM-102 in healthy subjects, abstr. A-1528. Abstr. 49th Intersci. Conf. Antimicrob. Agents and Chemother., San Francisco, CA.